%0 Journal Article
%T Role of sentinel lymph node biopsy with indocyanine green and site of injection in endometrial cancer.
%A Raimondo D
%A Raffone A
%A Aguzzi A
%A Bertoldo L
%A Seracchioli R
%J Curr Opin Oncol
%V 36
%N 5
%D 2024 Sep 1
%M 39106403
%F 3.915
%R 10.1097/CCO.0000000000001075
%X <B>OBJECTIVE: </B>The aim of the present narrative review is to summarize the state of art on sentinel lymph node biopsy (SLNB) in endometrial cancer, with a special focus on indocyanine green (ICG) as adopted tracer.<BR><B>RESULTS: </B>Over the years, the surgical nodal staging in patients with endometrial cancer has been intensively investigated. Traditionally, systematic pelvic and para-aortic lymphadenectomy represented the gold standard surgical treatment to assess nodal involvement of the tumor. Through the last two decades, SLNB has gradually replaced lymphadenectomy as a more targeted procedure. A great heterogeneity of tracers and injection techniques have been proposed to perform SLNB. However, no universally accepted recommendations are still available.<BR><B>CONCLUSIONS: </B>SLNB has nowadays almost replaced pelvic lymphadenectomy in low-risk endometrial cancers, offering a better safety profile while being related to a comparable nodal involvement sensitivity. Currently, ICG is considered to be the most used tracer among others. Different injection sites have been proposed, with different detection features. While ICG cervical injection is nowadays the suggested technique for SLNB, noncervical injection techniques, such as hysteroscopic and combined procedures, seem to have a better accuracy in para-aortic nodal assessment, which have a role in high-risk endometrial cancers.